{"id":305726,"date":"2019-11-20T18:00:17","date_gmt":"2019-11-21T02:00:17","guid":{"rendered":"https:\/\/nai500.com\/blog\/2019\/11\/healthcare-news-roundup-7\/"},"modified":"2019-11-20T18:02:52","modified_gmt":"2019-11-21T02:02:52","slug":"%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e6%96%b0%e9%97%bb%e7%b2%be%e9%80%89-10","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2019\/11\/%e5%8c%bb%e7%96%97%e4%bf%9d%e5%81%a5%e6%96%b0%e9%97%bb%e7%b2%be%e9%80%89-10\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u65b0\u95fb\u7cbe\u9009"},"content":{"rendered":"<h2><strong>Cellectis<\/strong><strong>\u57fa\u56e0\u7f16\u8f91\u4e13\u5229\u5728\u6b27\u6d32\u6709\u6548<\/strong><\/h2>\n<ul>\n<li>\u4e3a\u4e86\u5e94\u5bf9\u6311\u6218\uff08\u53cd\u5bf9\u7a0b\u5e8f\uff09\uff0c\u6b27\u6d32\u4e13\u5229\u5c40\u7ef4\u6301<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=CLLS\">Cellectis\uff08NASDAQ\uff1aCLLS\uff09<\/a>\u4e13\u5229\u7684\u6709\u6548\u6027\u3002\u6b27\u6d32\u4e13\u5229EP3004337\u6db5\u76d6\u4e86\u4f7f\u7528CRISPR \/ Cas9\u57fa\u56e0\u7f16\u8f91\u6280\u672f\u4e3a\u514d\u75ab\u7597\u6cd5\u5236\u5907T\u7ec6\u80de\u7684\u65b9\u6cd5\u3002<\/li>\n<li>\u8be5\u4e13\u5229\u6709\u6548\u671f\u81f32034\u5e74\u3002<\/li>\n<\/ul>\n<h2><strong>\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\u6572\u5b9aCelgene\u6536\u8d2d\u4ea4\u6613<\/strong><\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=BMY\"><strong>\u767e\u65f6\u7f8e\u65bd\u8d35\u5b9d\uff08<\/strong>NYSE\uff1aBMY<\/a>\uff09\u5df2\u4ee5\u73b0\u91d1\u3001\u666e\u901a\u80a1\u548c\u53ef\u4ea4\u6613\u7684\u6216\u6709\u4ef7\u503c\u6743\u4ee5\u603b\u8ba1$740\u4ebf\u6536\u8d2dCelgene\uff08NASDAQ\uff1aCELG\uff09\u3002<\/li>\n<\/ul>\n<h2><strong>FDA<\/strong><strong>\u6279\u51c6Alnylam\u7684Givosiran\u7528\u4e8eAHP<\/strong><\/h2>\n<ul>\n<li>\u5728\u4f18\u5148\u5ba1\u67e5\u72b6\u6001\u4e0b\uff0cFDA\u6279\u51c6\u4e86<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=ALNY\">Alnylam Pharmaceuticals\uff08ALNY + 7.5%\uff09<\/a>\u7528\u4e8e\u6025\u6027\u809d\u535f\u5549\u75c7\uff08AHP\uff09\u7684RNAi\u6cbb\u7597\u54c1\u724cGivlaari\u3002<\/li>\n<li>\u597d\u6d88\u606f\u5df2\u7ecf\u4f20\u5230RNAi\u5382\u5546Ionis Pharmaceuticals\uff08IONS + 3.5%\uff09\u548cAkcea Therapeutics\uff08AKCA + 8.7%\uff09\u3002<\/li>\n<\/ul>\n<h2><strong>\u8bfa\u534e\u5728\u52a0\u62ff\u5927\u542f\u52a8\u4eba\u5de5\u667a\u80fd\u5408\u4f5c<\/strong><\/h2>\n<ul>\n<li><a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=NVS\">\u8bfa\u534e\uff08NVS + 0.2%\uff09<\/a>\u81f4\u529b\u4e8e\u5229\u7528\u4eba\u5de5\u667a\u80fd\uff08AI\uff09\u6765\u6539\u53d8\u836f\u7269\u7684\u53d1\u73b0\u3001\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u65b9\u5f0f\u3002\u8bfa\u534e\u52a0\u62ff\u5927\u5206\u516c\u53f8\u5df2\u4e0e\u9b41\u5317\u514b\u4eba\u5de5\u667a\u80fd\u5b66\u9662Mila\u8fdb\u884c\u4e86\u4e3a\u671f\u4e09\u5e74\u7684\u5408\u4f5c\u3002<\/li>\n<li>\u52a0\u62ff\u5927\u8bfa\u534e\u5236\u836f\u516c\u53f8\u603b\u88c1\u514b\u91cc\u65af\u8482\u5b89\u00b7\u9a6c\u8d6b\uff08Christian Macher\uff09\u8868\u793a\uff1a\u201c\u901a\u8fc7\u5728Mila\u5f00\u5c55\u4e1a\u52a1\uff0c\u8bfa\u534e\u5c06\u80fd\u591f\u79ef\u6781\u53c2\u4e0e\u5176\u72ec\u7279\u7684\u3001\u5145\u6ee1\u6d3b\u529b\u7684\u516c\u53f8\u3001\u7814\u7a76\u4eba\u5458\u548c\u4f01\u4e1a\u5bb6\u751f\u6001\u7cfb\u7edf\u3002\u50cf\u8fd9\u6837\u7684\u8054\u76df\u5c06\u5e2e\u52a9\u6211\u4eec\u8d85\u8d8a\u4f20\u7edf\u5236\u836f\u884c\u4e1a\u7684\u8fd0\u8425\u6a21\u5f0f\uff0c\u62e5\u62b1\u533b\u7597\u4fdd\u5065\u521b\u65b0\u7684\u672a\u6765\uff0c\u5b9e\u73b0\u6211\u4eec\u91cd\u65b0\u60f3\u8c61\u533b\u5b66\u4ee5\u8fbe\u5230\u6539\u5584\u548c\u5ef6\u957f\u5bff\u547d\u7684\u76ee\u7684\u3002\u201d<\/li>\n<\/ul>\n<h2><strong>Dragonfly<\/strong><strong>\u4e0e\u827e\u4f2f\u7ef4\u5408\u4f5c\u6cbb\u7597\u81ea\u8eab\u514d\u75ab\u6027\u75be\u75c5\u548c\u80bf\u7624<\/strong><\/h2>\n<ul>\n<li>Dragonfly Therapeutics\u548c<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=ABBV\">\u827e\u4f2f\u7ef4(NYSE:ABBV)<\/a>\u5ba3\u5e03\u4e86\u4e00\u9879\u591a\u76ee\u6807\u7814\u7a76\u5408\u4f5c\uff0c\u65e8\u5728\u63a8\u52a8\u8bb8\u591aDragonfly\u57fa\u4e8eNK\u7ec6\u80de\u63a5\u5408\u5242\u7684\u514d\u75ab\u7597\u6cd5\u7528\u4e8e\u81ea\u8eab\u514d\u75ab\u548c\u80bf\u7624\u5b66\u9002\u5e94\u75c7\u3002<\/li>\n<li>\u901a\u8fc7\u6b64\u6b21\u5408\u4f5c\uff0c\u827e\u4f2f\u7ef4\u53ef\u4ee5\u9009\u62e9\u83b7\u5f97\u5168\u7403\u72ec\u5bb6\u77e5\u8bc6\u4ea7\u6743\u7684\u8bb8\u53ef\uff0c\u4ee5\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u9488\u5bf9\u4f7f\u7528Dragonfly\u7684TriNKET\u6280\u672f\u5e73\u53f0\u5f00\u53d1\u7684\u7279\u5b9a\u6807\u9776\u4ea7\u54c1\u3002<\/li>\n<li>\u827e\u4f2f\u7ef4\u5c06\u652f\u4ed8\u9884\u4ed8\u6b3e\u3001\u91cc\u7a0b\u7891\u4ed8\u6b3e\u548c\u7279\u8bb8\u6743\u4f7f\u7528\u8d39\u3002<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>In response to a challenge (opposition procedure), the European Patent Office has upheld the validity of Cellectis&#8217; (NASDAQ:CLLS) European Patent EP3004337 covering a method of preparing T cells for immunotherapy using the CRISPR\/Cas9 gene editing technology.<\/p>\n","protected":false},"author":9,"featured_media":268642,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[455,925,459],"class_list":["post-305726","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-455","tag-925","tag-459","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/305726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=305726"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/305726\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/268642"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=305726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=305726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=305726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}